- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Ochsner Names 2019 Alton Ochsner Award Relating Smoking and Disease Honorees
For 34 years, Ochsner Health System has annually recognized scientists who have made major contributions regarding the relationship between smoking and disease along with the development of innovative treatment modalities.
For 34 years, Ochsner Health System has annually recognized scientists who have made major contributions regarding the relationship between smoking and disease along with the development of innovative treatment modalities. The 2019 Alton Ochsner Award Relating Smoking and Disease Award has been bestowed to:
Paul M. Cinciripini, PhD (Professor, Department of Behavioral Science and Director, Tobacco Treatment Program at The University of Texas MD Anderson Cancer Center in Houston, Texas)
Edwin K. Silverman, MD, PhD (Professor of Medicine at Harvard Medical School and Physician, Department of Medicine, Pulmonary and Critical Care at Brigham and Women’s Hospital in Boston, Massachusetts)Each honoree will receive a $7500 honorarium, an award medallion, and a plaque describing key research findings.
Immune Checkpoint Inhibitors More Effective vs Bevacizumab in Nonsquamous NSCLC
August 6th 2025Bevacizumab combined with chemotherapy was not as effective in advanced driver gene-negative nonsquamous non–small cell lung cancer (NSCLC) compared with immune checkpoint inhibitors plus chemotherapy.
Read More
Higher Oxidative Balance Score Linked to Lower Systemic Inflammation, Study Finds
August 5th 2025Researchers discovered a significant negative correlation between an individual's oxidative balance score and systemic immune-inflammation index, highlighting the role of antioxidants in reducing inflammation.
Read More
